1
Nov
2022

Bluepharma Industria Farmaceutica S.A.

Exhibitor at CPHI Frankfurt 2022 stand 80B61, Integrated Pharma
About Us

The Bluepharma Group is today one of the most entrepreneurial and innovative in the pharmaceutical sector, having already achieved remarkable prestige not only in Portugal but also in the most demanding international markets.

Bluepharma Group offers an integrated drug development service (CRO/CDMO) from research, pre-formulation, and formulation development, up to commercial manufacturing  (including HPAPI). Bluepharma also supports non-clinical and clinical stages, including logistics and RA support (IMP, CMC).

  • PT
  • 2015
    On CPHI since
  • 5
    Certificates
  • 500 - 999
    Employees
Company types
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Contract Research Organisation
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Contact info
Event information
CPHI Frankfurt 2022
  • 1-3 November 2022
  • Messe Frankfurt, Germany
  • Visit us at stand 80B61, Integrated Pharma

Products Featured at CPHI Frankfurt 2022

  • Clinical Manufacturing

    Product Clinical Manufacturing

    .Integrated drug development service (CRO/CDMO) including clinical manufacturing and management.
    The range of activities offered by Bluepharma includes:
    - Clinical material cGMP manufacturing
    - Clinical supply management
    - clinical material
    - placebo
    - ...
  • Complex Sterile Formulations Contract Development

    Product Complex Sterile Formulations Contract Development

    +25 Years of accumulated experience in Lipid and polymer-based formulations.
    Regarding Complex Injectables, Bluepharma's focus is on Lipid-based, polymer-based, and Long-acting injectable (LAI) formulations. Bluepharma allies the scientific expertise with the technical capability to ensure the success...
  • Drug Delivery Platforms

    Product Drug Delivery Platforms

    Modified release, hot-melt extrusion, ODT, oral thin films, oral sprays, and polymer-based solutions,

    Our range of technologies covers solid dosage forms (IR and ER), polymer-based solutions, solid dispersions (hot-melt extrusion), oral sprays, oral thin films, and complex injectables ...
  • High Potent Manufacturing

    Product High Potent Manufacturing

    Manufacturing site dedicated to OSD forms incorporating high potent APIs EOB 4/5 (OEL up to < 0.03 µg/m3).
    Bluepharma has dedicated R&D centers and scale-up facilities that are well equipped in the formulation and pilot-scale equipment as well as analytics (covering a wide range of techniqu...
  • Pharmaceutical development (CDMO) & Exclusive portfolio

    Product Pharmaceutical development (CDMO) & Exclusive portfolio

    From research, pre-formulation, and formulation development, up to commercial manufacturing  (including HPAPI).
    Bluepharma offers an integrated drug development service (CDMO) from research, pre-formulation, and formulation development, up to commercial manufacturing ...